Literature DB >> 24105492

Heart failure in patients with atrial fibrillation is associated with a high symptom and hospitalization burden: the RealiseAF survey.

José Silva-Cardoso1, Oleg J Zharinov, Piotr Ponikowski, Lisa Naditch-Brûlé, Thorsten Lewalter, Sandrine Brette, P Gabriel Steg.   

Abstract

BACKGROUND: Atrial fibrillation (AF) and heart failure (HF) often coexist; the consequences of such coexistence are unclear. HYPOTHESIS: HF in patients with AF is associated with poor outcomes.
METHODS: This post hoc analysis of RealiseAF, a survey of AF patients, compared symptoms, hospitalizations, management, and AF control in patients with vs without HF. A total of 10,523 AF patients were analyzed according to presence/absence of HF.
RESULTS: History of HF was present in 45.8%, and in more patients with permanent vs persistent, paroxysmal, or first-episode AF (55.6%, 44.3%, 32.9%, and 29.8%, respectively; P < 0.0001). Patients with vs those without history of HF, and patients with HF and reduced ejection fraction (HF-REF) vs those with HF and a preserved ejection fraction (HF-PEF), had more frequent cardiovascular (CV) risk factors and more severe symptoms. Presence vs absence of HF, and HF-REF vs HF-PEF, were associated with lower rates of AF control (54.6% vs 62.8% and 49.3% vs 60.3%, respectively; both P < 0.0001). The rate-control strategy was used more frequently in HF patients, particularly those with HF-REF, than the rhythm-control strategy. CV hospitalizations occurred more frequently in patients with HF than those without (41.8% vs 17.5%; P < 0.001) and more frequently in patients with HF-REF than in those with HF-PEF (51.6% vs 35.6%; P < 0.0001).
CONCLUSIONS: AF patients with HF, particularly HF-REF, experience heavy symptom and hospitalization burdens, and have relatively low rates of AF control. Further studies are needed to identify ways to improve the management and treatment outcomes of this very high-risk patient population.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 24105492      PMCID: PMC6649623          DOI: 10.1002/clc.22209

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  9 in total

Review 1.  Addressing Multimorbidity and Polypharmacy in Individuals With Atrial Fibrillation.

Authors:  Fahad Shaikh; Lachlan B Pasch; Phillip J Newton; Beata V Bajorek; Caleb Ferguson
Journal:  Curr Cardiol Rep       Date:  2018-03-24       Impact factor: 2.931

2.  Atrial fibrillation symptom profiles associated with healthcare utilization: A latent class regression analysis.

Authors:  Megan M Streur; Sarah J Ratcliffe; David J Callans; M Benjamin Shoemaker; Barbara J Riegel
Journal:  Pacing Clin Electrophysiol       Date:  2018-05-15       Impact factor: 1.976

3.  Meta-analysis of randomized controlled trials on atrial fibrillation ablation in patients with heart failure with reduced ejection fraction.

Authors:  Aiman Smer; Mohsin Salih; Yousef H Darrat; Abdulghani Saadi; Raviteja Guddeti; Toufik Mahfood Haddad; Amjad Kabach; Mohamed Ayan; Alok Saurav; Hussam Abuissa; Claude S Elayi
Journal:  Clin Cardiol       Date:  2018-11-19       Impact factor: 2.882

4.  Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.

Authors:  Alanna M Chamberlain; Alvaro Alonso; Bernard J Gersh; Sheila M Manemann; Jill M Killian; Susan A Weston; Margaret Byrne; Véronique L Roger
Journal:  Am Heart J       Date:  2016-12-09       Impact factor: 4.749

5.  Heart failure with preserved ejection fraction: An alternative paradigm to explain the clinical implications of atrial fibrillation.

Authors:  Jonathan P Ariyaratnam; Adrian D Elliott; Ricardo S Mishima; Celine Gallagher; Dennis H Lau; Prashanthan Sanders
Journal:  Heart Rhythm O2       Date:  2021-12-17

6.  Clinical Implications of Heart Rate Control in Heart Failure With Atrial Fibrillation: Multi-Center Prospective Observation Registry (CODE-AF Registry).

Authors:  Shinjeong Song; Jum-Suk Ko; Hye Ah Lee; Eue-Keun Choi; Myung-Jin Cha; Tae-Hoon Kim; Jin-Kyu Park; Jung-Myung Lee; Ki-Woon Kang; Jaemin Shim; Jae-Sun Uhm; Jun Kim; Changsoo Kim; Jin-Bae Kim; Hyung Wook Park; Boyoung Joung; Junbeom Park
Journal:  Front Cardiovasc Med       Date:  2022-03-22

Review 7.  Dyspnea in patients with atrial fibrillation: Mechanisms, assessment and an interdisciplinary and integrated care approach.

Authors:  Rachel M J van der Velden; Astrid N L Hermans; Nikki A H A Pluymaekers; Monika Gawalko; Adrian Elliott; Jeroen M Hendriks; Frits M E Franssen; Annelies M Slats; Vanessa P M van Empel; Isabelle C Van Gelder; Dick H J Thijssen; Thijs M H Eijsvogels; Carsten Leue; Harry J G M Crijns; Dominik Linz; Sami O Simons
Journal:  Int J Cardiol Heart Vasc       Date:  2022-07-19

Review 8.  The effects of wenxin keli on p-wave dispersion and maintenance of sinus rhythm in patients with paroxysmal atrial fibrillation: a meta-analysis of randomized controlled trials.

Authors:  Yu Chen; Shaoping Nie; Hai Gao; Tao Sun; Xiaoqiu Liu; Fei Teng; Yanhui Xing; Wen Chen; Zhenpeng Zhang; Yonghong Gao; Jie Wang; Yanwei Xing; Hongcai Shang
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-04       Impact factor: 2.629

Review 9.  Calcium in the Pathophysiology of Atrial Fibrillation and Heart Failure.

Authors:  Nathan C Denham; Charles M Pearman; Jessica L Caldwell; George W P Madders; David A Eisner; Andrew W Trafford; Katharine M Dibb
Journal:  Front Physiol       Date:  2018-10-04       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.